Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Depreciation and Depletion (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Depreciation and Depletion for 17 consecutive years, with $132.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion fell 21.89% to $132.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $621.0 million through Dec 2025, down 4.61% year-over-year, with the annual reading at $621.0 million for FY2025, 4.61% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $132.0 million at Bristol Myers Squibb, down from $159.0 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $169.0 million in Q4 2024, with the low at $132.0 million in Q4 2025.
  • Average Depreciation and Depletion over 5 years is $151.4 million, with a median of $151.0 million recorded in 2023.
  • The sharpest move saw Depreciation and Depletion rose 11.68% in 2022, then dropped 21.89% in 2025.
  • Over 5 years, Depreciation and Depletion stood at $137.0 million in 2021, then increased by 11.68% to $153.0 million in 2022, then grew by 6.54% to $163.0 million in 2023, then rose by 3.68% to $169.0 million in 2024, then decreased by 21.89% to $132.0 million in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $132.0 million, $159.0 million, and $165.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.